Home
Site Search
Use small fonts Use medium fonts Use large fonts Email link to page PDF this page

Partners

Related people 1
Casey Chisick Casey Chisick
t: 416 869 5403
Email Casey Chisick email
Nancy Choi Nancy Choi
t: 416 860 6591
Email Nancy Choi email
Leonard Glickman Leonard Glickman
t: 416 869 5993
Email Leonard Glickman email
Jay Goldman Jay Goldman
t: 416 860 6474
Email Jay Goldman email
Alison Hayman Alison Hayman
t: 416 815 4240
Email Alison Hayman email
Bernice Karn Bernice Karn
t: 416 869 5721
Email Bernice Karn email
Emily Larose Emily Larose
t: 416 860 5217
Email Emily Larose email
Sean Maniaci Sean Maniaci
t: 416 860 6466
Email Sean Maniaci email
Cathy L. Mercer Cathy L. Mercer
t: 416 869 5772
Email Cathy L. Mercer email
Cameron A. Mingay Cameron A. Mingay
t: 416 860 6615
Email Cameron A. Mingay email
Stephen I. Selznick Stephen I. Selznick
t: 416 860 6883
Email Stephen I. Selznick email
John P. Vettese John P. Vettese
t: 416 869 5336
Email John P. Vettese email
Ann Watterworth Ann Watterworth
t: 416 869 5484
Email Ann Watterworth email

Associates

Related people 2
Jacqueline Richards Jacqueline Richards
t: 416 869 5391
Email Jacqueline Richards email
Stefanie Sebanc Stefanie Sebanc
t: 416 869 5405
Email Stefanie Sebanc email
Jonathan Sherman Jonathan Sherman
t: 416 869 5409
Email Jonathan Sherman email

Life Sciences Blog Graphic

Cannabis

Cassels Brock has distinguished itself at the forefront of the cannabis industry, providing a wide range of expertise in connection with general corporate, intellectual property, securities, regulatory, branding, celebrity endorsements and other related matters.

We act as corporate and securities counsel for various private and public companies in the cannabis industry, as well as licensed producers and late stage applicants on various matters including licensing, financings, M&A and go-public transactions.

We have also worked with many ancillary players in the cannabis space including private equity, device, branding, research and pharmacology companies. We have also acted in the capacity of underwriters’ counsel on numerous equity and debt financings and public offerings completed for cannabis companies.

Cassels Brock is respected for our contribution to thought leadership in connection with financing, structuring and regulatory issues in the cannabis industry, and are frequently called upon to write and speak on advancements and innovation in the industry and to work with prominent business and political leaders on groundbreaking issues.